Filtered By:
Condition: Cough

This page shows you your search results in order of date. This is page number 15.

Order by Relevance | Date

Total 318 results found since Jan 2013.

Respiratory Syncytial Virus Outbreak in a Veterans Affairs Long-term Care Facility
Conclusions Respiratory syncytial virus is highly infectious and can easily cause an outbreak in an LTCF. Polymerase chain reaction testing was contributory to identify cases rapidly. Rapid PCR results and intensified infection control measures were instrumental to halt the outbreak.
Source: Infectious Diseases in Clinical Practice - June 24, 2020 Category: Infectious Diseases Tags: Original Articles Source Type: research

COVID-19-related strokes in adults below 55  years of age: a case series
ConclusionStroke may be unrelated to age and the extent of lung involvement. However, different factors may play roles in co-occurrence of stroke and COVID-19 and its outcome. Future studies with long-term follow-up and more cases are needed to assess prognostic factors.
Source: Neurological Sciences - June 23, 2020 Category: Neurology Source Type: research

Potential mechanisms of hemorrhagic stroke in elderly COVID-19 patients.
Abstract The novel severe acute respiratory syndrome coronavirus 2 is the causative agent of coronavirus disease 2019, a new human infectious disease. While fever, cough, and respiratory distress are typical first symptoms, a fraction of those affected present instead with neurological symptoms suggestive of central nervous system compromise. This review summarizes the potential contribution of coronavirus disease 2019 to hemorrhagic stroke in the elderly and proposes possible mechanisms. Reports show that the most affected patients have underlying chronic diseases such as hypertension and diabetes, which are two ...
Source: Aging - June 10, 2020 Category: Biomedical Science Authors: Wang H, Tang X, Fan H, Luo Y, Song Y, Xu Y, Chen Y Tags: Aging (Albany NY) Source Type: research

Studying the Clinical Data of COVID Positive patients admitted to a tertiary care academic hospital
Conclusion: The most common presenting symptoms included fever, cough, and shortness of breath. Patients who required ICU admission at presentation had a worse prognosis. Those with greater severity of symptoms were mainly elderly patients among which the most common comorbidity was hypertention followed by cardiac disease.
Source: Journal of Emergencies, Trauma and Shock - June 9, 2020 Category: Emergency Medicine Authors: Julio Arrieta Sagar Galwankar Natalia Lattanzio Darrel Ray Amit Agrawal Source Type: research

Acquired angioedema induced by angiotensin-converting enzyme inhibitors - experience of a hospital-based allergy center.
Authors: Mihaela Leru P, Florin Anton V, Bocsan C, Muntean A, Boda D Abstract Angiotensin-converting enzyme inhibitors (ACEIs) represent an important group of pharmacological compounds, largely prescribed for more than 30 years. They have been extensively evaluated in clinical trials, demonstrating significant reduction of morbidity and mortality of patients with cardiovascular diseases, mainly high blood pressure, myocardial infarction, heart failure and stroke. Besides their beneficial effects and a general good safety profile, it was proven that ACEIs might also induce adverse effects in some patients, most nota...
Source: Experimental and Therapeutic Medicine - June 9, 2020 Category: General Medicine Tags: Exp Ther Med Source Type: research

A review of pathophysiology and neuropsychiatric manifestations of COVID-19
ConclusionThe neurological manifestations of the COVID-19 are varied and the data about this continue to evolve as the pandemic continues to progress.
Source: Journal of Neurology - June 2, 2020 Category: Neurology Source Type: research

Headache in the Older Population: Causes, Diagnoses, and Treatments
AbstractPurpose of ReviewPrimary headaches are less common and differ in presentation in older versus younger individuals. Secondary headaches become more common among older patients.Recent FindingsDiagnosis and management of headaches in those>  65 years are discussed. Migraine and tension-type headaches are rarely new onset in this age group and should be a diagnosis of exclusion. In older individuals, migraine is more likely to be bilateral with less sensory sensitivities. Migraine aura may present without headache; careful assessment is needed to exclude stroke. Other primary headaches discussed include cough, hy...
Source: Current Pain and Headache Reports - May 28, 2020 Category: Neurology Source Type: research

Unusual Symptoms of Coronavirus: What We Know So Far
While most people are familiar with the hallmark symptoms of COVID-19 by now—cough, fever, muscle aches, headaches and difficulty breathing—a new crop of medical conditions are emerging from the more than 4 million confirmed cases of the disease around the world. These include skin rashes, diarrhea, kidney abnormalities and potentially life-threatening blood clots. It’s not unusual for viruses to directly infect and affect different tissues and organs in the body, but it is a bit unusual for a primarily respiratory virus like SARS-CoV-2, which is responsible for COVID-19, to have such a wide-ranging reach...
Source: TIME: Health - May 19, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Coronavirus Concerns: Reports Of Strokes In Young People, CDC Adds New Symptoms
BOSTON (CBS) — There have been concerning reports of the coronavirus causing strokes in young people. Doctors at Mount Sinai in New York described five people under the age of 50 with little to no symptoms of COVID-19 who suffered severe strokes and tested positive for the virus. Other hospitals have reported similar cases. While the number of young people having strokes is low, it adds to the growing evidence that the coronavirus can trigger the formation of blood clots in the body, in the lungs as well as in the brain. If you develop sudden stroke symptoms, like facial droop, weakness in a limb, or slurring your sp...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 27, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Seen On WBZ-TV Syndicated CBSN Boston Syndicated Local Coronavirus Dr. Mallika Marshall Source Type: news

Landmark Phase 3 VOYAGER PAD Study of XARELTO ® (rivaroxaban) Plus Aspirin Shows Significant Benefit in Patients with Symptomatic Peripheral Artery Disease (PAD) after Lower-Extremity Revascularization
RARITAN, NJ, March 28, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the VOYAGER PAD study met its primary efficacy and principal safety endpoints, demonstrating the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily) plus aspirin (100 mg once daily) was superior to aspirin alone in reducing the risk of major adverse limb and cardiovascular (CV) events by 15 percent in patients with symptomatic peripheral artery disease (PAD) after lower-extremity revascularization, with similar rates of TIMI[1] major bleeding. VOYAGER PAD is the only study to show a significant benefit using...
Source: Johnson and Johnson - March 28, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Highlights Continued Commitment to Cardiovascular & Metabolic Healthcare Solutions with Late-Breaking Data at the First Fully Virtual American College of Cardiology Scientific Session
RARITAN, N.J., March 20, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that it will unveil late-breaking data from its leading cardiovascular and metabolism portfolio during the virtual American College of Cardiology’s 69th Annual Scientific Session together with the World Congress of Cardiology (ACC.20/WCC) on March 28-30, 2020. Notably, four late-breaking abstracts for XARELTO® (rivaroxaban) will be presented, including data from the Phase 3 VOYAGER PAD study in patients with symptomatic peripheral artery disease (PAD) after lower-extremity revascularization.Click to Tweet: Jan...
Source: Johnson and Johnson - March 20, 2020 Category: Pharmaceuticals Source Type: news

West Virginia Just Became the Last State to Report a COVID-19 Case. It Was Only a Matter of Time
Every U.S. state has now reported at least one confirmed case of COVID-19, following a positive diagnosis out of West Virginia. West Virginia Gov. Jim Justice confirmed the case Tuesday evening, saying it had been detected in the state’s Eastern Panhandle. “This is real and it’s really concerning,” Justice said. The case comes just a day after President Donald Trump praised Justice—who he called “Big Jim” at a Monday press conference—for “doing a good job” in keeping West Virginia free of COVID-19. Doctors, lawmakers and West Virginians were quick to point out, th...
Source: TIME: Health - March 17, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 News Desk Source Type: news

What Are Some Risk Factors for Cerebral Palsy?
Discussion The term, cerebral palsy, or CP has gone through many iterations with the first description in 1861 by W.J. Little who described it as “The condition of spastic rigidity of the limbs of newborn children.” The most recent definition is from Rosenbaun et al. in 2007 which states it is “a group of permanent disorders of the development of movement and posture, causing activity limitation, that are attributed to non-progressive disturbances that occurred in the developing fetal or infant brain. The motor disorders of cerebral palsy are often accompanied by disturbances of sensation, perception, cog...
Source: PediatricEducation.org - March 9, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Development of a new screening instrument for screening of dysphagia in geriatric patients: the dysphagia screening tool geriatrics.
CONCLUSION: The new screening tool is especially aimed at geriatric patients. It has advantages compared to previously recommended screening tests. Initial experiences with the instrument show good practicability and acceptance in geriatric teams. Further studies have to test the validity of the instrument. PMID: 32123997 [PubMed - as supplied by publisher]
Source: Zeitschrift fur Gerontologie und Geriatrie - March 1, 2020 Category: Geriatrics Authors: Jäger M, Thiem U, Stege H Tags: Z Gerontol Geriatr Source Type: research

Respiratory muscle training in stroke patients with respiratory muscle weakness, dysphagia, and dysarthria – a prospective randomized trial
Conclusions: Altogether, 6-week combined inspiratory and expiratory RMT is feasible as adjuvant therapy for stroke patients to improve fatigue level, respiratory muscle strength, lung volume, respiratory flow, and dysarthria. Clinical trial registration number (Clinical Trial Identifier): NCT03491111.
Source: Medicine - March 1, 2020 Category: Internal Medicine Tags: Research Article: Clinical Trial/Experimental Study Source Type: research